- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01672294
Caregiver Outlook: An Intervention to Improve Caregiving in Serious Illness
Informal caregivers provide a majority of care for patients during serious illness. Lack of preparation and completion may leave caregivers less capable of caring for a loved one or making crucial decisions influencing care.
This study will examine whether a preparation and completion intervention reduces caregiver anxiety, depression, anticipatory grief, and burden and improves patient quality of life and health care use.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators propose a randomized control trial to evaluate an intervention of preparation and completion with Veterans and their caregivers during serious illness. Specific aims are to 1) Evaluate the impact of the caregiver Outlook intervention on caregiver anxiety, depression, anticipatory grief, completion, and burden; 2) Evaluate the impact of the home versus in hospital, emergency department, or nursing facility; 3) Evaluate the impact of the intervention session's qualitative content, examining variation associated with selected demographic variables, quality of family communication, and stage of illness on change.
Caregivers in the first group ("Treatment", or "Preparation and life completion") will meet with a facilitator three times for a period of forty-five minutes each. In the first session, subjects will be asked to discuss issues related to relationship life review.
In session two, participants will be asked to speak in more depth about issues such as regret and forgiveness. In the final session, subjects will focus on legacy and celebration. Caregivers in the second group ("attention control" or "relaxation meditation") will meet with a facilitator three times for a period of forty-five minutes each and be asked to listen to a non-guided relaxation compact disk (CD) or participate in a guided relaxation exercise.
Participants in both groups will receive pre and post-test measures administered by a blinded interviewer. Outcome measures will be measures by the Functional Assessment of Cancer Therapy - General (FACT-G), Quality of life scale, FACIT-sp sub-scale, Anticipatory Grief Scale, Caregiver Reaction Assessment, the Qual-E completion and preparation sub-scales, and patient days at home.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Durham VA Medical Center, Durham, NC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with advanced cancer/Congestive heart failure/COPD/End stage renal disease who have a primary caregiver. Caregivers of Durham VAMC patients with advanced disease.
Exclusion Criteria:
- No caregiver present.
- Caregiver with Cognitive impairment/inability to speak on phone/non-English speaking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: treatment
three facilitator-led end-of-life preparation and completion sessions with a facilitator with both patient and caregiver
|
Caregiver subjects will discuss life review, issues of forgiveness and heritage and legacy.
|
|
Active Comparator: attention control
three facilitator led sessions of listening to a relaxation CD.
|
Caregiver subjects will listen to a non-guided relaxation CD with facilitator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver Anxiety
Time Frame: Measured at baseline, 5 weeks, and 8 weeks
|
Profile of Moods States (POMS) anxiety sub-scale The anxiety sub-scale from the modified Brief Profile of Mood States (POMS),7110 a six-item measure of psychological distress.
Individual items used a 5 point Likert scale (0-4).
The sub-scale minimum score was 0 and maximum was 24 (more anxious ).
|
Measured at baseline, 5 weeks, and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spirituality
Time Frame: Measured at baseline, 5 weeks, and 8 weeks
|
Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being (FACIT-SP) subscale.
The 12-item measure assess spiritual well-being: faith, meaning, and purpose.
Individual items use a 5 point likert scale (0-4).
The scale minimum score is 0 (negative well being) and maximum is 48 (positive well being).
|
Measured at baseline, 5 weeks, and 8 weeks
|
|
Depression
Time Frame: Measured at baseline, 5 weeks, and 8 weeks
|
Centers for Epidemiologic Study of Depression short form (CES-D) is a 10-item measure of depression.
Items are rated on a 4 point Likert scale (0-3) with total scores ranging from 0 to 30.
Higher scores indicate greater depressive symptoms
|
Measured at baseline, 5 weeks, and 8 weeks
|
|
Patient Days of VA Hospital Use
Time Frame: In the 6 months after randomization
|
The number of days that a patient used either the VA emergency department (ED) or was an inpatient at a VA hospital in the 6 months following randomization.
Inclusion of non-VA utilization was made unpractical due to the long delay in filing for non VA reimbursement (up to 2 years).
The original variable was Day AT home, defined to be 180 days minus the days in ED or inpatient hospital.
This was changed to days of use due to distribution/modeling considerations.
|
In the 6 months after randomization
|
|
Caregiver Burden
Time Frame: Measured at baseline, 5 weeks, and 8 weeks
|
Caregiver Reaction Assessment (CRA).
The Caregiver Reaction Assessment is a 24-item multidimensional instrument designed to measure a caregiver's reactions to caregiving for family members with a variety of chronic illnesses.
The esteem subscale has 7 items with a 5 level Likert scale: 1=Strongly Disagree to 5=Strongly Agree.
The score is the average of the 7 items ranging from a low score of 1 associated with negative reactions and high score of 5 with positive reactions.
|
Measured at baseline, 5 weeks, and 8 weeks
|
|
Caregiver Completion
Time Frame: Measured at baseline, 5 weeks, and 8 weeks
|
Quality of life at the End of Life (Family Edition) is a 17-item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support.
The 3-item Life Completion subscale uses a 5 point (0-4) Likert scale.
The subscale ranges from 0 (poor) to 4 (better outcome).
|
Measured at baseline, 5 weeks, and 8 weeks
|
|
Prolonged Grief - Number of Participants With Anticipatory Grief
Time Frame: Measured at baseline, 5 weeks, and 8 weeks
|
The Prolong Grief Disorder scale is a clinically-based diagnosis determination scale modified for this study.
The components/requirements that were dropped were a) diagnosis should not be made until at least 6 months since death, and b) the disturbance is not better accounted for major depressive disorder, generalized anxiety disorder or post traumatic stress disorder.
The outcome was a dichotomized variable with 1 indicating symptoms of prolonged grief are present and 0 indicating insufficient symptoms.
|
Measured at baseline, 5 weeks, and 8 weeks
|
|
Caregiver Preparation
Time Frame: Measured at baseline, 5 weeks, and 8 weeks
|
Quality of life at the End of Life (Family Edition) is a 17-item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support.
The 5-item preparation subscale uses a 5 point (0-4) Likert scale.
The subscale ranges from 0 (poor) to 4 (better outcome).
|
Measured at baseline, 5 weeks, and 8 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Karen E Steinhauser, PhD, Durham VA Medical Center, Durham, NC
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIR 11-347
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Preparation and life completion
-
VA Office of Research and DevelopmentCompletedCancer | Chronic Obstructive Pulmonary Disease | Congestive Heart FailureUnited States
-
VA Office of Research and DevelopmentCompletedCancer | Chronic Obstructive Pulmonary Disease (COPD) | End Stage Renal Disease (ESRD) | Congestive Heart Failure (CHF)United States
-
Institut Cancerologie de l'OuestTerminated
-
Children's Hospital ColoradoCompletedAnxiety | DistressUnited States
-
Centre Hospitalier Universitaire DijonCompletedQuality of Life | Systemic Auto-immune DiseasesFrance
-
Centre Hospitalier Universitaire DijonCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
US Department of Veterans AffairsTerminated
-
Worcestershire Acute Hospitals NHS TrustCompletedVaricose Veins of Lower LimbUnited Kingdom
-
University of CalgaryAlberta Children's HospitalUnknownMagnetic Resonance ImagingCanada